The “Valley of Death” sounds like a scary place from “Lord of the Rings” or “Game of Thrones” that our heroes have to navigate to reach safety. The reality is not that different. It’s the space that young companies have to navigate from having a good idea to getting financial backing, so they can move … Continue reading How CIRM support helped a promising approach to type 1 diabetes get vital financial backing
Industry News
How small talk led to a big break; a summer internship at CIRM
At CIRM, California's Stem Cell Agency, we are fortunate to work with some amazing people. This summer we added another name that list when Melissa Cairos joined us for an internship. Melissa is now on to the next part of her adventure, as a policy wonk in Washington DC., but before she left we asked … Continue reading How small talk led to a big break; a summer internship at CIRM
Has Regenerative Medicine Come of Age?
For the past few years the Signals blog site - which offers an insiders’ perspectives on the world of regenerative medicine and stem cell research - has hosted what it calls a "Blog Carnival". This is an event where bloggers from across the stem cell field are invited to submit a piece based on a … Continue reading Has Regenerative Medicine Come of Age?
Regenerative Medicine by the numbers: a snapshot of how the field is progressing
Statistics don’t usually make for very exciting blog fodder, but they can be useful in charting progress. Case in point, the recent quarterly report from the Alliance for Regenerative Medicine (ARM), a global advocate and industry group for the field. In the report ARM takes an in-depth look at cell therapy, gene therapy, tissue engineering … Continue reading Regenerative Medicine by the numbers: a snapshot of how the field is progressing
CIRM-funded medical research and development company does $150M deal to improve care for dialysis patients
Nearly half a million Americans with kidney disease are on dialysis, so it’s not surprising the CIRM Board had no hesitation, back in July 2016, in funding a program to make it easier and safer to get that life-saving therapy. That's why it’s gratifying to now hear that Humacyte, the company behind this new dialysis … Continue reading CIRM-funded medical research and development company does $150M deal to improve care for dialysis patients
CIRM applauds FDA crackdown on stem cell clinics that “peddle unapproved treatments.”
CIRM is commending the US Food and Drug Administration (FDA) for its action against two stem cell clinics offering unapproved therapies. On Wednesday, the FDA filed two complaints in federal court seeking a permanent injunction against California Stem Cell Treatment Center Inc. and US Stem Cell Clinic LLC. of Sunrise, Florida. The FDA says the … Continue reading CIRM applauds FDA crackdown on stem cell clinics that “peddle unapproved treatments.”
CIRM’s Industry Alliance Program: Facilitating Partnerships to Advance Stem Cell Therapies
Some things are better together. Take for instance macaroni and cheese, eggs and bacon, cookies and ice cream. Each of these things are fine on their own, but together, they become something more powerful and delicious. The right partnerships can bring out the best in things. At CIRM, we fully embrace this concept. That’s why … Continue reading CIRM’s Industry Alliance Program: Facilitating Partnerships to Advance Stem Cell Therapies
If you’re into stem cell manufacturing, this is the conference for you!
Fulfilling CIRM’s mission doesn’t just mean accelerating promising stem cell treatments to patients. It also involves accelerating the whole field of regenerative medicine, which involves not just research, but developing candidate treatments, manufacturing cell therapies, and testing these therapies in clinical trials. Manufacturing and the pre-clinical safety evaluation of cell therapies are topics that don’t … Continue reading If you’re into stem cell manufacturing, this is the conference for you!
Recap of the 2018 Alliance for Regenerative Medicine Cell and Gene Therapy State of the Industry
What happened in the Cell and Gene Therapy sector in 2017, and what should we be looking out for in 2018? Over 500 executives, investors, scientists and patient advocates gathered together yesterday to find out at the Alliance for Regenerative Medicine (ARM) State of the Industry Briefing in San Francisco, California. ARM Chairman, Robert Preti, … Continue reading Recap of the 2018 Alliance for Regenerative Medicine Cell and Gene Therapy State of the Industry
How CIRM funding creates additional financial support for stem cell research in California
CIRM’s 2017 Annual Report will be going live online very soon. In anticipation of that we are highlighting some of the key elements from the report here on the Stem Cellar. CIRM funds stem cell research. We all know that. What you may not know is that CIRM funds also help bring in additional funding … Continue reading How CIRM funding creates additional financial support for stem cell research in California